SENSEX
NIFTY
GOLD
USD/INR

Weather

image 15    C

Economy News

The Economic Times

Economy / The Economic Times

details

Merck & Co to create a separate cancer unit as patent cliff looms

Merck & Co is restructuring by splitting its drug division into two separate businesses. The change is designed to spotlight its fastest-growing medicines as the blockbuster cancer therapy Keytruda nears patent expiration. The company plans to emphasize newer products, including a pneumonia vaccine and a treatment for lung disease, as key drivers of its next growth phase.

25 Feb 2026 12:01 am